Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Linear transformer power supply
Carrying case
Question and answer system wherein experts are associated with models and have response rates that are associated with time intervals
Apparatus and method for exerting force on a subject tissue
Cavernous nerve stimulation via unidirectional propagation of action potentials
Device for installing conducting components in structures
Memory elements with increased write margin and soft error upset immunity
  Randomly Featured Patents
Apparatus for aligning stators and rotors
Automobile body dent puller
Pharmaceutical compositions for headache, migraine, nausea and emesis
Collection and processing apparatus of repeatedly used recording media
Open-tubular supercritical fluid chromatography
Modulator circuit with linear and non-linear control
Stabilized aqueous amide antimicrobial composition
Method for controlling growth of tobacco suckers
Valve timing control apparatus having cylinder discriminating function
Method and apparatus for detecting and responding to downed conductors